4.7 Article

Clinical validation of saliency maps for understanding deep neural networks in ophthalmology

期刊

MEDICAL IMAGE ANALYSIS
卷 77, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.media.2022.102364

关键词

Deep neural networks; Saliency maps; Diabetic retinopathy; Neovascular age-related macular; degeneration

资金

  1. German Ministry of Science and Education (BMBF) [01GQ1601, 01IS18039A]
  2. German Science Foundation [BE5601/4-1, EXC 2064, 390727645]
  3. Novartis AG

向作者/读者索取更多资源

Deep neural networks have achieved physician-level accuracy on imaging-based medical diagnostic tasks. To address the lack of transparency in their decision mechanisms, explanation methods such as saliency maps have been proposed. This study validates the quality of saliency maps for retinal images using different network architectures and explanation methods, and finds that the choice of architecture and method significantly influences the map's quality.
Deep neural networks (DNNs) have achieved physician-level accuracy on many imaging-based medical diagnostic tasks, for example classification of retinal images in ophthalmology. However, their decision mechanisms are often considered impenetrable leading to a lack of trust by clinicians and patients. To alleviate this issue, a range of explanation methods have been proposed to expose the inner workings of DNNs leading to their decisions. For imaging-based tasks, this is often achieved via saliency maps. The quality of these maps are typically evaluated via perturbation analysis without experts involved. To facilitate the adoption and success of such automated systems, however, it is crucial to validate saliency maps against clinicians. In this study, we used three different network architectures and developed ensembles of DNNs to detect diabetic retinopathy and neovascular age-related macular degeneration from retinal fundus images and optical coherence tomography scans, respectively. We used a variety of explanation methods and obtained a comprehensive set of saliency maps for explaining the ensemble-based diagnostic decisions. Then, we systematically validated saliency maps against clinicians through two main analyses - a direct comparison of saliency maps with the expert annotations of disease-specific pathologies and perturbation analyses using also expert annotations as saliency maps. We found the choice of DNN architecture and explanation method to significantly influence the quality of saliency maps. Guided Backprop showed consistently good performance across disease scenarios and DNN architectures, suggesting that it provides a suitable starting point for explaining the decisions of DNNs on retinal images. (c) 2022 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据